|
|
|
|
|
Polymerase chain reaction (PCR) is a rapid in
vitro procedure for enzymatic amplification of specific segments of DNA,
typically in the range of 100-300 bp long. PCR allows rapid replication of
a single copy of DNA into millions of copies. For example, starting with
about 100 ngm of genomic mammalian DNA (~104 molecules), the
standard PCR protocol yields an easily visible product on an ethidium
bromide stained gel. For this reason, PCR is one of the widely used
techniques in modern medicine and has had a great impact in every aspect of
modern molecular biology. |
|
|
|
|
|
PCR
is used in the following conditions: |
|
|
|
Assays for the presence of infectious agents |
|
Prenatal diagnosis of genetic diseases |
|
Direct cloning from genomic DNA or cDNA |
|
Quantitation of rare DNA by PCR |
|
Amplification of RNA by PCR (RT-PCR) |
|
In vitro mutagenesis and engineering of DNA |
|
Genetic fingerprinting of forensic samples |
|
Analysis of allelic sequence variations |
|
|
|
|
|
|
|
|
|
Analysis of RNA transcript structure |
|
Ligation-mediated PCR for genomic sequencing and
footprinting |
|
Direct nucleotide sequencing of genomic DNA or
cDNA |
|
Direct sequencing of PCR products |
|
Preparation of ss products for dideoxy
sequencing |
|
Preparation of ds products for dideoxy
sequencing |
|
Labeling products for chemical sequencing |
|
Preparation of ss and ds products for cycle
sequencing and automated sequencing |
|
|
|
|
|
|
The
PCR consists of repetition of the following three steps. |
|
Denaturation: in this step the two strands of
the DNA are separated. This is normally done at 94 ° C. |
|
Annealing: in this step the primers bind to the
DNA. This is normally achieved at 55° C |
|
Extension: in this phase, using the DNA
template, the polymerase adds the dNTPs to the primer and causes the
extension of the primer. This is normally done at 72° C |
|
|
|
|
|
|
|
|
The denaturation, annealing and extension steps
are then repeated in succession for 25-35 cycles, hence the term polymerase
chain reaction. |
|
|
|
|
|
|
|
|
The amplified products are then evaluated by the
following means: |
|
The products are subjected to gel
electrophoresis and are viewed by staining with ethidium bromide. This
allows determining the size of the amplified products. The size of the
amplified product should correspond to the expected size of the band. |
|
The identity of the amplified products are
verified by restriction enyme digestion, sequencing and/or Southern
blotting. |
|
|
|
|
DNA fragment to be amplified |
|
Two single stranded oligonucleotide primers
flanking the DNA segment |
|
DNA polymerase |
|
Deoxyribonucleoside triphosphates (dTNPs) |
|
Buffer |
|
Salts |
|
Thermocycler |
|
After
addition of the PCR components the microfuge is layered with mineral oil to
prevent evaporation. |
|
|
|
|
|
Each PCR reaction should be optimized. The following parameters play
a major role in insuring that the PCR works: |
|
Purity and amount of the template |
|
Concentration of MgCI2 |
|
Reagent purity |
|
Nuclease contamination |
|
DNA contamination |
|
Appropriately designed primers |
|
Taq DNA Polymerase |
|
Concentration |
|
Activity |
|
Heat stability |
|
|
|
|
|
|
|
Primers should be able to hybridize specifically
to the sequence of interest |
|
|
|
|
|
|
|
Concentration of deoxyribonucleoside
Triphosphates (200 mM) |
|
Thermocycling Parameters |
|
Denaturation temperature |
|
Annealing temperature |
|
Extension |
|
"Ramp time" |
|
|
|
|
|
|
|
|
|
|
The size of the amplified product should be
optimal (~ 300 bp) |
|
Appropriate primer length (20-30 bases; 16 bases
if found once in human genome) |
|
Appropriate primer sequence |
|
GC content similar to template |
|
Avoiding stretches of polypurines or
polypyrimidines |
|
Use of computer prediction programs |
|
Avoiding self complementarity to prevent
"Primer-Dimer formation” |
|
|
|
|
Avoiding hairpin loop formation |
|
The 3’ ends of the primer should not complement
non-specific targets such as
vector, cDNA insert, genomic DNA or PCR product |
|
The melting points of both primers should be
similar. |
|
The 3’ terminal nucleotides of primers should
end in a G or C, or the same base. |
|
Primers should have a moderate GC content. |
|
|
|
|
|
|
Primers should have a moderate GC content. |
|
A run of >6 G’s or A’s should be avoided |
|
AAG at 3’ end should be avoided |
|
GGAG at 3’ end should be avoided |
|
|
|
|
|